DAWES KAREN A sold 1.1% of their position (1K shares) of REPLIGEN CORP on the open market
Open‑market sale worth $193.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/28/2024ACC: 0000950170-24-022581
+8.25K
Net shares
Net buyer
$193.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
9.25K acquired · 1K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.63K
Price / share
$42.07
Trade value
$194.62K
% of position
5.5%
2/27/2024
83.74K→88.37K
Common Stock
Direct
Shares
−1K
Price / share
$193.35
Trade value
$193.35K
% of position
1.1%
2/27/2024
88.37K→87.37K
Total
Net shares
+3.63K
Net value
$1.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2024 | M · Option Exercise | +4.63K | $42.07 | $194.62K | 5.5% | 83.74K | 88.37K |
| Common Stock Direct | 2/27/2024 | S · Sale | −1K | $193.35 | $193.35K | 1.1% | 88.37K | 87.37K |
| Total | +3.63K | $1.27K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4.63K shares
Shares
+4.63K
Strike price
42.07
Held after
0.00
Exercisable
—
2/27/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4.63K shares | 2/27/2024 | M · Option Exercise | +4.63K | 42.07 | — | 0.00 |